
Today on Drug Discovery & Development
FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11
The Pfizer-BioNTech vaccine booster had been previously limited in the U.S. to individuals at least 12 years old, but now children as young as 5 are eligible, thanks to an expanded emergency use authorization related to the vaccine. The agency agreed to expand the vaccine’s use in children to “provide continued protection against COVID-19,” said…Massachusetts is competing for ARPA-H biomedical research center
The U.S. government is planning to establish the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research. The new federal research agency will not be based alongside its NIH parent in Bethesda, Maryland. After winning authorization to create the agency, Sen. Edward J. Markey (D-Mass.) and several colleagues in Massachusetts are asking the…Drug Discovery and Development See More >

Massachusetts is competing for ARPA-H biomedical research center
The U.S. government is planning to establish the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research. The new federal research agency will not be based alongside its NIH parent in Bethesda, Maryland. After winning authorization to create the agency, Sen. Edward J. Markey (D-Mass.) and several colleagues in Massachusetts are asking the…
Sponsored Content See More >
Genomics/Proteomics See More >

DNA Script raises $165M Series C for DNA printing platform
DNA Script announced today that it raised $165 million in a Series C financing round, bringing its total capital raised to $280 million. South San Francisco-based DNA Script earmarked the funds raised to accelerate expansion and commercialization for the company’s Syntax benchtop nucleic acid printer and to broaden its portfolio of products powered by enzymatic…
Infectious Disease See More >

FDA allows booster dose Pfizer-BioNTech COVID-19 vaccine in children 5 to 11
The Pfizer-BioNTech vaccine booster had been previously limited in the U.S. to individuals at least 12 years old, but now children as young as 5 are eligible, thanks to an expanded emergency use authorization related to the vaccine. The agency agreed to expand the vaccine’s use in children to “provide continued protection against COVID-19,” said…

AstraZeneca paying up to $157M for broad-spectrum monoclonal antibodies against COVID

NIH licenses COVID-19 research technologies to WHO initiative

FDA approves Olumiant for treating some hospitalized COVID-19 patients

How Karius aims to transform the diagnosis of infections with a non-invasive liquid biopsy
Oncology See More >

Black Diamond analysis highlights 22 new oncogenic HER2 driver mutations
On the heels of announcing a restructuring plan that reduces its workforce by 30%, Black Diamond Therapeutics (Nasdaq:BDTX) has announced that its discovery engine was featured in the peer-reviewed Cancer Research journal. The journal is published by American Association for Cancer Research (AACR). A paper highlighted in the journal explained how the company’s Mutation-Allostery-Pharmacology (MAP) discovery…

Imfinzi with chemotherapy gets FDA priority review for locally advanced or metastatic biliary tract cancer

Novartis reveals positive Phase 3 data for tislelizumab plus chemotherapy in esophageal cancer

AstraZeneca and Daiichi Sankyo win new breakthrough therapy designation for Enhertu
